Navigation Links
Biosyntrx, Inc. Appoints New Board Member & New VP of Operations
Date:1/12/2012

COLORADO SPRINGS, Colo., Jan. 12, 2012 /PRNewswire/ -- Biosyntrx, Inc. CEO Ellen Troyer today announced that Akos Feher has been appointed to the Biosyntrx Board of Directors.  Mr. Feher lives in Playa Del Rey, CA and holds degrees in engineering with an MBA from the University Of Southern California Marshall School Of Business. He has been a Biosyntrx strategic planning consultant for the past two years.  Mr. Feher is an innovative, passionate and profit-driven professional with more than 12 years of experience in complex projects, brands and business infrastructure including consumer electronics, medical devices and dietary supplements.

(Logo:  http://photos.prnewswire.com/prnh/20120112/SF34130LOGO)

The Biosyntrx board also promoted David Amess from Business Development Director to Vice President of Operations.  Mr. Amess has been with Biosyntrx for more than four years.  He brings a Business Administration degree and almost 20 years of experience in banking, finance, and customer service management.  David is Six Sigma certified, with a focus on statistical methods for problem solving and business model projections.

"Biosyntrx sales and revenue increased in 2011 despite today's economy," said Ellen Troyer.  "We welcome 2012 with a revised business plan, an exciting pipeline, improved operations, an 'on fire' board and executive management team with engaged and energized employees, consultants and distributors.  Opportunities are knocking in the supplement industry and Biosyntrx maintains a global open door policy to legitimate opportunity."

Spencer Thornton, MD, the Nashville TN based Biosyntrx President says, "Akos Feher and David Ames are passionate and exceptionally talented team players who will serve our stockholders and customers well in the new positions they hold."

"The appointment of David Amess as Vice President for Operations with his Six Sigma Certification is going to be a real plus in my opinion.  Adding Akos Feher to the Board of Directors will give quality business judgment and experience," said Jerre Freeman, MD. 

"Biosyntrx has proven they have the creativity required to survive economic difficulty.  I applaud these appointments and look forward to watching them grow," said Robert Osher, MD.

About Biosyntrx:  Biosyntrx is an eye-care-specific privately held company incorporated in South Carolina with customer service offices and inside product sales located in downtown Columbia. The company's executive offices including product research and development, web site development, operations, business development, marketing and education are located in Colorado Springs, Colorado.  The primary Biosyntrx eye care-specific products are BioTears, a patented product that addresses the systemic nutrient needs of the dry eye patient. Macula Complete, a potent full-spectrum multiple designed for the diagnosed AMD, or those concerned about optimal full-body health and lack of energy; Oculair, a less potent full-body multiple and Avantrx, a meal-time portion-control product.

www.biosyntrx.com  


'/>"/>
SOURCE Biosyntrx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, a ... amplified its effort during National Breast Cancer Awareness ... cancer risks. ... Oncology calculated that more than 10 million American ... mutations in BRCA1 or BRCA2 and have not had ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance in ... medical-grade battery-powered display stand specifically designed for endoscopy environments. An innovative ... into a clinical solution to support the improvement of patient outcomes, ... Design ... Solution ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... , ... PurhealthRX , a leading Health and Nutrition Company, is announcing ... full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing the ... incorporated into liquid products, while reducing costs to end users. , The team of ...
(Date:10/13/2017)... ... , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to ... unique items from across the nation, this holiday-themed event will raise funds and awareness ... VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Planet Fitness, ... the U.S., announced today its plans to open a flagship location in Covington, LA ... the former Rooms To Go store next to Office Depot in the Holiday Square ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
Breaking Medicine News(10 mins):